ERBB2 and breast cancer: Buonomo et al. compared lymph node involvement and occurrence of distant metastases in 324 breast cancer patients and indicated that Her2+ patients and the basal patients show the highest and the lowest risk, respectively, of distant metastasis based on lymph node status [31].